This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
Genomic Biomarker Testing
PEACE-3 Trial
PROfound Trial
PSMAfore Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
BOND-003 Cohort P
CORE-001 Study
CORE-008
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Daniel D. Joyce, MD, MS
Bladder Cancer
Non-Muscle Invasive Bladder Cancer
Ashish Kamat, MD
Muscle-Invasive Bladder Cancer
Advanced & Metastatic Bladder Cancer (mUC)
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher® Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
mCRPC with Bone Metastasis
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
Testicular, Penile & Rare GU Malignances
Testicular Cancer
Functional Urology
Functional Urology
Alan J. Wein, MD, PhD (hon.)
Urologic Catheters - CAUTI Challenges
Videos
Exclusives
Conferences
Disparities: Social Determinants of Health
Exclusive Collaborations
Health Policy in Urological Diseases
Independent Medical Education
Journal Clubs
Practice Guidelines Reviews
The Prostate Cancer Foundation
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Functional Urology
Men's Health
Pelvic Health
Actionable Clinical Data
Bladder Cancer
NMIBC with CIS: Evidence, Practice & Emerging Research
Risk-Stratified NMIBC Management
Trials in Progress
Prostate Cancer
Localized Prostate Cancer
CLARIFY
ESCAPE
FORT
NRG-GU 0101
RTIRE
High Risk BCR HSPC
ARASTEP
Oligometastatic Prostate Cancer
METANOVA
mHSPC
ARASEC
ASPIRE
MEVPRO-3
mCRPC
ECLIPSE
LEGION-100
MEVPRO-1 & 2
PROMISE
SECuRE
Bladder Cancer
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SNMMI 2026
ASCO 2026
AUA 2026
APCCC 2026
PSMA and Beyond 2026
All Conferences
View All
PCF
UroToday Home
Conference Highlights
AUA 2019
AUA 2019
Prostate Cancer
Bladder Cancer
Renal Cancer
Testis & Penile Cancers
Lower Urinary Tract Conditions
GU Reconstruction
Infections & Inflammation
Laparoscopic / Robotic Surgery
Sexual Function
Stone Disease
Press Releases
AUA 2019 Prostate Cancer
Viewing 1-20 of 113 articles
AUA 2019: MRI Targeted Therapies for Prostate Cancer: Ready for Prime Time?
AUA 2019: Facility-level Variation in Pelvic Lymph Node Dissection During Radical Prostatectomy and Effect on Overall Survival in Men with Clinically Localized High-risk Prostate Cancer
AUA 2019: Cryopreserved Placental Tissue Allograft Accelerates Time to Continence After Robotic Radical Prostatectomy
AUA 2019: Predictive Factors of Postoperative Quality of Life, Erectile Function and Continence After Robot-assisted Radical Prostatectomy
AUA 2019: Panel Discussion: Opioids and Urology – Opioids and Hypogonadism
AUA 2019: Panel Discussion: Opioids and Urology - Ideal Postoperative Pain Management During an Opioid Epidemic
AUA 2019: Diagnostic Accuracy of Targeted Prostate Biopsies: Comparing Micro-Ultrasound with Multiparametric MRI for the Detection of Prostate Cancer
AUA 2019: Site of Care and its Impact on Receipt of Palliative Care for Black Men with Metastatic Prostate Cancer
AUA 2019: Men With BRCA1 and BRCA2 Mutations and Low/Intermediate Grade Prostate Cancer May Harbor Additional Genomic Alterations of More Aggressive Disease: Implications for Active Surveillance
AUA 2019: Transperineal vs. Transrectal MRI/US Fusion for Prostate Cancer Detection
AUA 2019: The Efficacy and Feasibility of Radiation Therapy to the Primary Tumor in Patients with Metastatic Castration Resistant Prostate Cancer
AUA 2019: In the Decade of MRI Based Active Surveillance, When Do Biopsy Upgrading Rates Stabilize?
AUA 2019: Racial Disparities in Axial Imaging Utilization Across the Pennsylvania Urologic Regional Collaborative (PURC)
AUA 2019: 17-gene Genomic Prostate Score as a Predictor of Adverse Pathology for Men on Active Surveillance
AUA 2019: Rates and Patterns of Metastases in Patients with Node-Negative Prostate Cancer at Radical Prostatectomy Experiencing PSA Failure: Post-Hoc Analysis of RTOG 9601 Trial Data
AUA 2019: TRoMbone: Testing Radical Prostatectomy in Men with Oligometastatic Prostate Cancer that has Spread to the Bone
AUA 2019: Ramon Guiteras Lecture: More Arrows in Our Quiver—Targeting the Adaptive Molecular Landscape of Advanced Prostate Cancer
AUA 2019: Estimation of the Risk of Missing Adverse Pathological Prostate Cancer Features after Salvage Radical Prostatectomy in Patients Eligible for Focal Salvage Therapies
AUA 2019: Understanding the Role of Statin Use on Advanced Prostate Cancer Outcomes: Does the Statin Type, Cumulative Dose or Duration Impact Survival?
AUA 2019: Multivisceral Surgery in Men with Locally Advanced, Symptomatic Castration-Resistant Prostate Cancer
1
2
3
4
5
6
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free